Portugal’s medication authority has withdrawn four types of tablets from sale in Portugal with immediate effect, telling people who are using them to consult their doctors straight away.
The pills, three of which are versions of paracetamol, are not considered to conform to the system of good manufacturing practices.
They are: Paracetamol Bluepharma 1000 mg, Paracetamol Sandoz 500 mg, Supofen 1000 mg and Metformina Mylan.
A statement from the medication authority explains that “following an inspection by Infarmed to manufacturer Granules India Ltd (Gagillapur, India) non conformities in the system of good manufacturing practices were detected”.
These non conformities relating to the “activity of granulation and primary packaging” of the pills.
Chemists or other outlets selling the meds must now remove them from the shelves, and “proceed with their return” to Granules India Ltd.
News website Business Standard reported earlier this week that the company has recently received “11 observations from Infarmed” after the latter conducted a renewal inspection on the company’s Gagillapur facility which “manufactures pharmaceutical formulation intermediates and finished dosages”.